Opportunity Information: Apply for PA 07 307

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Drug Abuse Aspects of HIV/AIDS (R01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
  • This funding opportunity was created on Dec 5, 2008 and posted on Jan 17, 2007.
  • Applicants must submit their applications by Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Special district governments Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) County governments City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized).
  • Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith based or community based organizations can apply.
Apply for PA 07 307

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Drug Abuse Aspects of HIV/AIDS (R01) opportunity (Funding Opportunity Number PA-07-307) is a discretionary grant program from the National Institutes of Health, specifically the National Institute on Drug Abuse (NIDA). It supports research that sits at the intersection of drug use, addiction, and HIV/AIDS, with a clear emphasis on how shifts in the HIV epidemic are changing prevention needs in the United States and abroad. The core intent is to stimulate rigorous, research-driven approaches that explain and reduce HIV risk connected to drug abuse, and to build or refine prevention strategies that match today’s realities rather than older epidemic patterns.

A central theme of the announcement is that the HIV/AIDS epidemic has been evolving in ways that demand updated research questions and intervention designs. In the United States, the FOA highlights trends such as the increasing overrepresentation of minorities and women among new AIDS cases, along with the importance of heterosexual sex as a transmission route. Within this context, NIDA is looking for studies that deepen understanding of HIV risk and outcomes where drug use is a contributing driver, and that produce novel or improved prevention interventions that can respond to these demographic and behavioral shifts. The focus is not only on documenting risk, but on developing and testing prevention approaches that work in the populations now most affected and in the real settings where risk occurs.

The announcement also places substantial weight on international relevance and translation. It encourages research on adapting and implementing interventions proven effective in the U.S. for use in other communities and in international settings, recognizing that prevention strategies often cannot be copied directly without cultural, structural, or health-system adaptation. At the same time, it explicitly invites learning in the other direction as well: studying different conditions and cultural contexts abroad to sharpen understanding of why HIV-related risks, morbidity, and mortality vary across diverse populations. In practical terms, this means projects can be oriented toward cross-cultural adaptation, implementation and dissemination questions, and comparative studies that reveal mechanisms driving differences in HIV risk and health outcomes in drug-using or drug-affected populations.

The funding mechanism is the NIH Research Project Grant (R01), which is typically used for substantial, hypothesis-driven projects that require a fuller scale of effort than smaller exploratory grants. This FOA is described as running in parallel with two companion announcements of identical scientific scope that use other mechanisms: PA-07-308 (R03) and PA-07-309 (R21). That parallel structure is meant to accommodate different project stages and sizes, from exploratory work to larger, more definitive studies, while keeping the scientific priorities aligned.

Funding availability and the number of awards are not fixed; awards are contingent on the availability of funds and on receiving a sufficient number of scientifically meritorious applications. The announcement notes multiple receipt dates, indicating that applications were accepted on recurring cycles rather than a single one-time deadline (with the specifics referenced in the full announcement). The opportunity was originally posted on January 17, 2007, and later archived on February 2, 2010, reflecting its historical grant cycle and indicating that applicants would need to consult current NIH opportunities for active equivalents.

Eligibility is broad and includes many organization types across the public, private, and nonprofit sectors. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; nonprofits with and without 501(c)(3) status (excluding institutions of higher education in those categories); for-profit organizations (including small businesses and other for-profits); public housing authorities/Indian housing authorities; Native American tribal governments (federally recognized) and other tribal organizations; and additional entities as clarified in the full eligibility text. Importantly, the FOA specifies that foreign institutions are eligible to apply, eligible federal agencies can apply, and faith-based or community-based organizations may also apply. There is no cost sharing or matching requirement listed, which generally means applicants are not required to contribute non-federal funds as a condition of receiving the award.

Administratively, this opportunity is categorized under CFDA 93.279 (Drug Abuse and Addiction Research Programs), and it is framed as a health and education-related research activity. For applicants needing the original details, the full announcement link is provided through the NIH Grants Guide, and contact support is routed through the NIH Office of Extramural Research (OER) webmaster for access or technical linking issues.

Frequently Asked Questions (FAQs)

What is the name of this grant opportunity?

The opportunity is titled The Drug Abuse Aspects of HIV/AIDS (R01).

What is the Funding Opportunity Number (FON)?

The Funding Opportunity Number is PA-07-307.

Which agency is offering this opportunity?

This is a discretionary grant program from the National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA).

What is the main purpose of the FOA?

The FOA is intended to stimulate rigorous, research-driven projects that explain and reduce HIV risk connected to drug abuse, and to develop or refine HIV prevention strategies that fit current realities of the epidemic rather than older patterns.

What scientific area does the FOA focus on?

It focuses on research at the intersection of drug use, addiction, and HIV/AIDS, including how drug abuse contributes to HIV risk, morbidity, and mortality, and how prevention approaches can be improved in today’s most affected populations and settings.

Why does the FOA emphasize “shifts” in the HIV epidemic?

The announcement highlights that the HIV/AIDS epidemic has been evolving, which requires updated research questions and intervention designs. It specifically points to trends in the United States such as the increasing overrepresentation of minorities and women among new AIDS cases and the importance of heterosexual sex as a transmission route.

Does the FOA support only studies that document risk, or also intervention work?

It supports more than documenting risk. The FOA emphasizes developing, improving, and testing prevention approaches that work in the populations now most affected and in real-world settings where risk occurs.

Does this opportunity include international research or global health work?

Yes. The FOA places substantial weight on international relevance and translation, encouraging research that adapts and implements interventions (including those proven effective in the U.S.) for other communities and international settings, and research that examines how different cultural and structural contexts shape HIV-related risks and outcomes.

Can projects focus on adapting U.S.-proven interventions for other settings?

Yes. The announcement encourages studies on adapting and implementing interventions that have been effective in the U.S. for use in other communities and international contexts, recognizing that effective prevention often requires cultural, structural, and health-system adaptation.

Does the FOA also encourage learning from international settings back to the U.S. research context?

Yes. It explicitly invites learning in the other direction as well, including studying conditions and cultural contexts abroad to sharpen understanding of why HIV-related risks, morbidity, and mortality vary across diverse populations.

What types of research questions are encouraged internationally?

Based on the FOA description, international-oriented projects may include cross-cultural adaptation work, implementation and dissemination questions, and comparative studies aimed at identifying mechanisms that drive differences in HIV risk and health outcomes in drug-using or drug-affected populations.

What grant mechanism does PA-07-307 use?

It uses the NIH Research Project Grant (R01) mechanism, which is commonly used for substantial, hypothesis-driven projects requiring a fuller scale of effort than smaller exploratory grants.

Are there related opportunities using other NIH mechanisms?

Yes. The FOA is described as running in parallel with two companion announcements of identical scientific scope that use other mechanisms: PA-07-308 (R03) and PA-07-309 (R21).

How is this FOA’s funding availability described?

Funding availability and the number of awards are not fixed. Awards are contingent on the availability of funds and on receiving a sufficient number of scientifically meritorious applications.

Is there a single deadline, or are there multiple receipt dates?

The announcement notes multiple receipt dates, indicating applications were accepted on recurring cycles rather than through a single one-time deadline (with specifics referenced in the full announcement).

When was this funding opportunity originally posted?

It was originally posted on January 17, 2007.

Is this FOA still active?

The opportunity was later archived on February 2, 2010, reflecting its historical grant cycle. For active equivalents, applicants would need to consult current NIH opportunities.

What is the CFDA number associated with this program?

The CFDA number is 93.279 (Drug Abuse and Addiction Research Programs).

What general activity area does the FOA fall under?

It is framed as a health and education-related research activity.

Who is eligible to apply?

Eligibility is broad across public, private, nonprofit, and for-profit sectors. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; nonprofits with and without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories); for-profit organizations (including small businesses and other for-profits); public housing authorities/Indian housing authorities; Native American tribal governments (federally recognized) and other tribal organizations; and additional entities as clarified in the full eligibility text.

Are foreign institutions allowed to apply?

Yes. The FOA specifies that foreign institutions are eligible to apply.

Can federal agencies apply?

Yes. The FOA indicates that eligible federal agencies can apply.

Are faith-based or community-based organizations eligible?

Yes. The FOA states that faith-based and community-based organizations may apply.

Is cost sharing or a match required?

No cost sharing or matching requirement is listed, which generally indicates applicants are not required to contribute non-federal funds as a condition of receiving the award.

Where can applicants find the original full announcement?

The full announcement is available through the NIH Grants Guide via the provided link in the opportunity information.

Who should be contacted for access or technical linking issues related to the announcement?

Support is routed through the NIH Office of Extramural Research (OER) webmaster for access or technical linking issues.

Browse more business programs for HIV and AIDS support, Drug Abuse Research and Prevention

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Mental Health Consequences Of Violence And Trauma (R01)

Previous opportunity: Drug Abuse Aspects of HIV/AIDS (R03)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 07 307

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 07 307) also looked into and applied for these:

Funding Opportunity
Research on Clinical Decision Making in Life Threatening Illness (R21) Apply for PA 07 316

Funding Number: PA 07 316
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Early Career Award in Chemistry of Drug Abuse and Addiction (ECHEM) NIDA (R03) Apply for PAS 07 327

Funding Number: PAS 07 327
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Drug Abuse, Risky Decision Making and HIV/AIDS (R03) Apply for PAS 07 326

Funding Number: PAS 07 326
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Drug Abuse, Risky Decision Making and HIV/AIDS (R01) Apply for PAS 07 324

Funding Number: PAS 07 324
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Drug Abuse, Risky Decision Making and HIV/AIDS (R21) Apply for PAS 07 325

Funding Number: PAS 07 325
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Academic Industrial Partnerships for Development and Validation of In Vivo Imaging Systems and Methods for Cancer Investigations (R01) Apply for PAR 07 214

Funding Number: PAR 07 214
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NIDA Research Education Grants in Drug Abuse and Addiction (R25) Apply for PAR 07 221

Funding Number: PAR 07 221
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Neuroscience Research on Drug Abuse (R01) Apply for PA 07 226

Funding Number: PA 07 226
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Neuroscience Research on Drug Abuse (R21) Apply for PA 07 227

Funding Number: PA 07 227
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Neuroscience Research on Drug Abuse(R03) Apply for PA 07 228

Funding Number: PA 07 228
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $50,000
Collaborative Clinical Trials in Drug Abuse (R01) Apply for PAR 07 232

Funding Number: PAR 07 232
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01) Apply for PA 07 329

Funding Number: PA 07 329
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21) Apply for PA 07 331

Funding Number: PA 07 331
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03) Apply for PA 07 330

Funding Number: PA 07 330
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medications Development for the Treatment of Amphetamine and Amphetamine Like Related Disorders (R01) Apply for PA 07 333

Funding Number: PA 07 333
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medications Development for the Treatment of Amphetamine and Amphetamine Like Related Disorders (R21) Apply for PA 07 334

Funding Number: PA 07 334
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Development of Animal Models and Related Biological Materials For Research (R21) Apply for PA 07 336

Funding Number: PA 07 336
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
HIV Treatment Adherence Research (R01) Apply for PA 07 338

Funding Number: PA 07 338
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
HIV Treatment Adherence Research (R03) Apply for PA 07 339

Funding Number: PA 07 339
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
HIV Treatment Adherence Research (R21) Apply for PA 07 340

Funding Number: PA 07 340
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 307", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.